Advanced tube formation assay using human endothelial colony forming cells for in vitro evaluation of angiogenesis.
10.4196/kjpp.2018.22.6.705
- Author:
Hyunsook LEE
1
;
Kyu Tae KANG
Author Information
1. College of Pharmacy, Duksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Korea. ktkang@duksung.ac.kr
- Publication Type:Original Article
- Keywords:
Angiogenesis;
Endothelial colony forming cells;
Real-time cell recorder;
Tube formation assay
- MeSH:
Angiogenesis Inhibitors;
Attention;
Drug Discovery;
Endothelial Cells;
Fibroblast Growth Factor 2;
Humans*;
In Vitro Techniques*;
Vascular Endothelial Growth Factor A
- From:The Korean Journal of Physiology and Pharmacology
2018;22(6):705-712
- CountryRepublic of Korea
- Language:English
-
Abstract:
The tube formation assay is a widely used in vitro experiment model to evaluate angiogenic properties by measuring the formation of tubular structures from vascular endothelial cells (ECs). in vitro experimental results are crucial when considered the advisability of moving forward to in vivo studies. Thus, the additional attentions to the in vitro assay is necessary to improve the quality of the pre-clinical data, leading to better decision-making for successful drug discovery. In this study, we improved the tube formation assay system in three aspects. First, we used human endothelial colony forming cells (ECFCs), which are endothelial precursors that have a robust proliferative capacity and more defined angiogenic characteristics compared to mature ECs. Second, we utilized a real-time cell recorder to track the progression of tube formation for 48 hours. Third, to minimize analysis error due to the limited observation area, we used image-stitching software to increase the microscope field of view to a 2×2 stitched area from the 4× object lens. Our advanced tube formation assay system successfully demonstrated the time-dependent dynamic progression of tube formation in the presence and absence of VEGF and FGF-2. Vatalanib, VEGF inhibitor, was tested by our assay system. Of note, IC₅₀ values of vatalanib was different at each observation time point. Collectively, these results indicate that our advanced tube formation assay system replicates the dynamic progression of tube formation in response to angiogenic modulators. Therefore, this new system provides a sensitive and versatile assay model for evaluating pro- or anti-angiogenic drugs.
